Independent & educational platform Not a government body. No link or affiliation with any government organisation. Made for learning only. Test only systems you own or are authorised to test. Become a Partner or Sponsor → Full disclaimer

CVE-2026-43574

medium

OpenClaw before 2026.4.12 contains an improper authorization vulnerability in helper-backed channels where empty resolved approver lists are interpreted as exp…

Vendor / product: Openclaw — openclaw

OpenClaw before 2026.4.12 contains an improper authorization vulnerability in helper-backed channels where empty resolved approver lists are interpreted as explicit approval authorization. Attackers can resolve pending approvals without proper authorization by exploiting this logic flaw if they know an approval id.

CVSS
6.5
6.5 (CVSS v3.1)
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N
Severity source: NVD CVSS v3.1 (disclosure@vulncheck.com)
Timeline (UTC)
Published: 2026-05-05 12:16
Modified: 2026-11-11 21:10
NVD status: Analyzed
Last synced 5 hours ago
Verified against the source API 2026-11-11 21:11 UTC
Exploitation
Not listed in CISA KEV (as of last catalog sync)
Absence from KEV does not mean a CVE is not exploited. Exploitation status: unknown (no authoritative evidence in our sources).

Affected products

openclaw / openclaw <2026.4.12

Weakness classification (CWE)

Source: NVD / CISA. “NVD-CWE-Other” and “NVD-CWE-noinfo” mean NVD could not assign a specific weakness.

Mitigation & advisories

Vendor advisory: https://github.com/openclaw/openclaw/security/advisories/GHSA-49cg-279w-m73x
Patch / mitigation: https://github.com/openclaw/openclaw/commit/0a105c0900de701d2ee9f1abc96b017afbd0afdd

References

Data sources

NVD CVE API 2.0 — fetched 2026-11-11 21:11 UTC · record ↗

Learn the basics

Understanding CVEs and CVSS Scores

Related CVEs